AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Purple Biotech Ltd.

Regulatory Filings Dec 28, 2020

7004_rns_2020-12-28_019ba3ac-d793-4663-9f05-f302bfcd8422.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

_________ false

���� ����� ��"� 2 122
PURPLE BIOTECH LTD
Corporation no: 520031238 12724
- - -
Israel Securities Authority Tel Aviv Stock Exchange C100 ( Public ) Reported via MAGNA: 28/12/2020
www.isa.gov.il www.tase.co.il Reference: 2020-02-140778 Time of broadcast: 11:55 11:55

Immediate Report about change of identifying detailsSection 35AE(d) of the Securities Law, 5728-1968

The corporation�s new address as of 28/12/2020 is:No 4   St. Oppenheimer, Science Park   City RehovotZip Code 7670104   State _________   Country Israel

Telephone number : 03-9333121   Telephone number2 : 03-9311321

Fax number: 03-5097196

The corporation e-mail address : [email protected]

Company site: www.kitovpharma.com

Stock Exchange/Market: NASDAQ CM

����� ����� �����
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 08/12/2020
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101   , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: [email protected]   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMA LTD, KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: Masas Ludmer Adi Position of Signatory in the reporting corporation: Company Controller Name of Employer Company:
Address: Menachem Begin Drive 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: [email protected] 1
Israel

Talk to a Data Expert

Have a question? We'll get back to you promptly.